V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002578 | 330001416 | 1.8 | 90.8 | Adjuvant (A) | 2015-04-12 | 2015-04-14 | Doxorubicin 75mg/m2 | N | N | 330010456 | DOXORUBICIN |
| 330002579 | 330001416 | 1.76 | 52.7 | Curative (C) | 2016-12-05 | 2016-12-20 | Carboplatin AUC 6 - 10 | N | N | 330010456 | CARBOPLATIN |
| 330002580 | 330001417 | 1.65 | 71.6 | null | 2013-10-21 | 2013-11-11 | Cisplatin + Doxorubicin | N | N | 330010467 | CISPLATIN + DOXORUBICIN |
| 330002581 | 330001418 | 1.61 | 107 | Curative (C) | null | 2016-05-19 | Liposomal Doxorubicin (Caelyx) | N | N | 330010479 | LIPOSOMAL DOXORUBICIN |
| 330002582 | 330001418 | 1.65 | 4 | null | 2017-12-12 | 2018-01-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 330010479 | CARBOPLATIN + PACLITAXEL |
| 330002583 | 330001418 | 1.88 | 79 | Disease modification (D) | 2015-06-05 | 2015-06-24 | Liposomal Doxorubicin (Caelyx) | N | N | 330010479 | LIPOSOMAL DOXORUBICIN |
| 330002586 | 330001419 | 1.6 | 73.8 | null | 2014-05-03 | 2014-06-03 | Carboplatin AUC 2 - 5 | 02 | N | 330010501 | CARBOPLATIN |
| 330002587 | 330001419 | 1.57 | 52 | Palliative (P) | 2016-09-23 | 2016-10-07 | DOXORUBICIN | 02 | Y | 330010501 | DOXORUBICIN |
| 330002589 | 330006748 | 1.86 | 137 | Palliative (P) | null | 2015-12-03 | Carboplatin + Paclitaxel (weekly) | N | N | 330010510 | CARBOPLATIN + PACLITAXEL |
| 330002590 | 330001421 | 1.6 | 61.9 | Curative (C) | 2018-02-23 | 2018-02-23 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 330010517 | LIPOSOMAL DOXORUBICIN |
| 330002591 | 330001422 | 1.7 | 108.2 | Neo-adjuvant (N) | 2014-09-15 | 2014-09-23 | Carboplatin AUC 6 - 10 | 2 | N | 330010532 | CARBOPLATIN |
| 330002592 | 330001423 | 1.78 | 62.4 | Palliative (P) | 2012-11-28 | 2013-06-01 | Liposomal Doxorubicin (Caelyx) | N | N | 330010537 | LIPOSOMAL DOXORUBICIN |
| 330002593 | 330001424 | 1.65 | 44.1 | Palliative (P) | 2018-05-26 | 2018-06-02 | Doxorubicin 75mg/m2 | N | N | 330010546 | DOXORUBICIN |
| 330002594 | 330001424 | null | 61.3 | Palliative (P) | 2013-12-11 | 2013-12-16 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330010546 | CARBOPLATIN + PACLITAXEL |
| 330002595 | 330001425 | 1.71 | 65.95 | Neo-adjuvant (N) | 2017-03-03 | 2017-03-31 | CARBOPLATIN + ETOPOSIDE | N | N | 330010562 | CARBOPLATIN + ETOPOSIDE |
| 330002596 | 330001426 | 1.75 | 58.6 | null | 2013-03-26 | 2013-04-19 | Rituximab (Maintenance) | 02 | N | 330010563 | RITUXIMAB |
| 330002597 | 330006750 | 1.64 | 91.4 | Curative (C) | 2013-09-22 | 2013-10-11 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330010567 | LIPOSOMAL DOXORUBICIN |
| 330002598 | 330006750 | 1.73 | 155 | Palliative (P) | 2015-03-09 | 2015-03-16 | Doxorubicin 75mg/m2 | 2 | N | 330010567 | DOXORUBICIN |
| 330002600 | 330001428 | null | 70 | null | 2015-02-22 | 2015-03-08 | Rituximab | N | N | 330010585 | RITUXIMAB |
| 330002601 | 330001429 | 0 | 73.2 | Not known (9) | 2014-07-04 | 2014-07-17 | Bendamustine+Rituximab (1st Course) | 02 | N | 330010592 | BENDAMUSTINE + RITUXIMAB |
| 330002602 | 330001430 | 1.75 | null | Not known (9) | null | 2018-01-08 | Bendamustine+Rituximab (1st Course) | N | N | 330010596 | BENDAMUSTINE + RITUXIMAB |
| 330002603 | 330001431 | 1.51 | 67.4 | null | 2013-09-01 | 2013-09-15 | Cisplatin + Doxorubicin | N | N | 330010600 | CISPLATIN + DOXORUBICIN |
| 330002604 | 330001431 | 1.73 | null | null | 2016-01-12 | 2016-01-16 | Rituximab | N | N | 330010600 | RITUXIMAB |
| 330002605 | 330001431 | 1.69 | null | Neo-adjuvant (N) | 2015-08-15 | 2015-08-18 | Cisplatin + Doxorubicin | N | N | 330010600 | CISPLATIN + DOXORUBICIN |
| 330002606 | 330001432 | null | 67 | Curative (C) | 2017-12-21 | 2017-12-22 | Carboplatin AUC 6 - 10 | 02 | N | 330010605 | CARBOPLATIN |
| 330002607 | 330006752 | 1.55 | 31.7 | Curative (C) | 2014-04-08 | 2014-04-08 | Carboplatin + Etoposide iv&po | 2 | null | 330010610 | CARBOPLATIN + ETOPOSIDE |
| 330002608 | 330001433 | 1.54 | 66 | null | 2016-11-14 | 2016-11-14 | Carboplatin AUC 6 - 10 | 2 | null | 330010616 | CARBOPLATIN |
| 330002609 | 330006753 | 1.66 | 111 | Curative (C) | 2012-12-27 | 2013-01-09 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330010618 | CARBOPLATIN + ETOPOSIDE |
| 330002610 | 330001434 | null | 63.6 | Palliative (P) | 2014-03-29 | 2014-03-30 | Liposomal Doxorubicin (20mg/m2) | 2 | Y | 330010648 | LIPOSOMAL DOXORUBICIN |
| 330002611 | 330001434 | 0 | null | Palliative (P) | 2018-01-10 | 2018-01-15 | Liposomal Doxorubicin (20mg/m2) | N | N | 330010648 | LIPOSOMAL DOXORUBICIN |
| 330002612 | 330001435 | 1.75 | 62.2 | Palliative (P) | null | 2015-12-07 | CARBOPLATIN + ETOPOSIDE | null | null | 330010652 | CARBOPLATIN + ETOPOSIDE |
| 330002613 | 330001435 | null | 64.1 | Palliative (P) | 2014-06-21 | 2014-06-28 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330010652 | CARBOPLATIN + PACLITAXEL |
| 330002614 | 330001435 | 1.73 | 84 | Adjuvant (A) | null | 2014-10-08 | Cisplatin + Doxorubicin | null | null | 330010652 | CISPLATIN + DOXORUBICIN |
| 330002615 | 330001436 | null | null | Adjuvant (A) | 2014-05-11 | 2014-05-12 | Cisplatin + Doxorubicin | null | N | 330010664 | CISPLATIN + DOXORUBICIN |
| 330002616 | 330001437 | 1.74 | null | null | null | 2015-05-22 | Rituximab | null | null | 330010669 | RITUXIMAB |
| 330002617 | 330001438 | 1.7 | 70 | Palliative (P) | 2014-03-27 | 2014-04-15 | Cisplatin + Doxorubicin | N | N | 330010672 | CISPLATIN + DOXORUBICIN |
| 330002618 | 330006756 | 1.59 | null | Disease modification (D) | 2015-01-18 | 2015-01-21 | Rituximab | null | null | 330010673 | RITUXIMAB |
| 330002619 | 330006756 | 1.66 | 46 | Curative (C) | 2015-01-28 | 2015-01-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330010673 | BENDAMUSTINE + RITUXIMAB |
| 330002620 | 330001439 | 1.57 | 53 | Palliative (P) | 2015-04-26 | 2015-04-26 | Doxorubicin 75mg/m2 | 2 | N | 330010676 | DOXORUBICIN |
| 330002621 | 330001439 | 1.66 | 66.6 | Disease modification (D) | 2017-03-24 | 2017-03-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330010676 | BENDAMUSTINE + RITUXIMAB |
| 330002622 | 330001439 | 1.65 | null | Palliative (P) | 2017-03-01 | 2017-03-01 | Rituximab | 2 | N | 330010676 | RITUXIMAB |
| 330002623 | 330001440 | 1.72 | 84 | Adjuvant (A) | 2017-05-05 | 2017-05-10 | CARBOPLATIN + PACLITAXEL | 02 | N | 330010684 | CARBOPLATIN + PACLITAXEL |
| 330002624 | 330001440 | 1.91 | 58.5 | Neo-adjuvant (N) | 2014-06-08 | 2014-06-09 | Cisplatin + Doxorubicin | 02 | N | 330010684 | CISPLATIN + DOXORUBICIN |
| 330002625 | 330009653 | 1.72 | 70 | Curative (C) | 2015-10-14 | 2015-10-18 | Liposomal Doxorubicin (Caelyx) | N | null | 330010691 | LIPOSOMAL DOXORUBICIN |
| 330002626 | 330001441 | 1.7 | null | Palliative (P) | 2017-11-25 | 2017-12-08 | Carboplatin + Etoposide iv&po | 2 | N | 330010693 | CARBOPLATIN + ETOPOSIDE |
| 330002627 | 330001442 | 1.57 | 66 | Curative (C) | 2013-05-17 | 2013-05-28 | Rituximab | N | N | 330010695 | RITUXIMAB |
| 330002628 | 330006759 | 1.7 | null | null | 2014-06-17 | 2014-07-02 | Cisplatin + Doxorubicin | 2 | N | 330010701 | CISPLATIN + DOXORUBICIN |
| 330002629 | 330001443 | 1.61 | null | Curative (C) | 2017-08-25 | 2017-09-12 | Carboplatin AUC 2 - 5 | 02 | N | 330010709 | CARBOPLATIN |
| 330002630 | 330001443 | 1.55 | 19.9 | Neo-adjuvant (N) | 2014-11-25 | 2014-11-27 | Cisplatin + Doxorubicin | 02 | N | 330010709 | CISPLATIN + DOXORUBICIN |
| 330002631 | 330001444 | 1.7 | 77 | Adjuvant (A) | 2016-06-03 | 2016-06-07 | DOXORUBICIN | 2 | null | 330010717 | DOXORUBICIN |